We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ViroMed

News List

Viromed acquires US-based DNA Production Facility biospectrumasia
October 15, 2018
The facility in San Diego is equipped with a 500 L fermenter, cell culture lab and QC test lab, and has extra space for future expansion, making it an ideal site for both biopharmaceutical R&D and commercial-scale plasmid DNA production
ViroMed Secures DNA Production Facility in the U.S. contractpharma
August 22, 2018
ViroMed has acquired a plasmid DNA production facility in San Diego, CA from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral neuropathy (PDPN) neari
ViroMed Secures DNA Production Facility in the US americanpharmaceuticalreview
August 21, 2018
ViroMed announced the acquisition of a plasmid DNA production facility in San Diego, California from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral